sacituzumab govitecan
gilead sciences
['tropics-02', 'sacituzumab govitecan', 'breast']
primary results from tropics-02: phase 3 study of sacituzumab govitecan versus tpc in patients hr+/her2- advanced #breastcancer another great presentation by #asco22 #oncoalerttoptweet 
Associate Professor, Florence University, Italy. Clinical Oncologist with focus on breast, radiation, research. Opinions are my own. RT not endorsement.